Opt-out HIV and hepatitis C testing at the dallas county Jail: Uptake, prevalence, and demographic characteristics of testers

Public Health Reports

Volumn 132, Issue 6, 2017, Pages 617-621

  de La Flor, Carolina ^a,b   Porsa, Esmaeil ^b   Nijhawan, Ank E ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

Author keywords

Health disparities; Hepatitis C virus; HIV AIDS; Incarceration; Opt out; Testing

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BABY BOOMER; BLACK PERSON; CAUCASIAN; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PHLEBOTOMY; PREVALENCE; PRIORITY JOURNAL; PRISON; PRISONER; UNITED STATES; AGE DISTRIBUTION; ANCESTRY GROUP; BLOOD; MASS SCREENING; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; SEX RATIO; STATISTICS AND NUMERICAL DATA; TEXAS;

ADULT; AGE DISTRIBUTION; CONTINENTAL POPULATION GROUPS; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; PRISONERS; PRISONS; SEX DISTRIBUTION; TEXAS;

EID: 85039850809     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/0033354917732755     Document Type: Article

References (21)

1. Rich JD, Beckwith CG, Macmadu A, et al. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. Lancet. 2016;388(10049):1103-1114.
2. Gough E, Kempf MC, Graham L, et al. HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis. BMC Public Health. 2010;10:777.
3. Solomon L, Montague BT, Beckwith CG, et al. Survey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment. Health Aff (Millwood). 2014;33(3):434-442.
4. Chodos AH, Ahalt C, Cenzer IS, Myers J, Goldenson J, Williams BA. Older jail inmates and community acute care use. Am J Public Health. 2014;104(9):1728-1733.
5. Iroh PA, Mayo H, Nijhawan AE. The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105(7):e5-e16.
6. Beckman AL, Bilinski A, Boyko R, et al. New hepatitis C drugs are very costly and unavailable to many state prisoners. Health Aff (Millwood). 2016;35(10):1893-1901.
7. Lucas KD, Eckert V, Behrends CN, Wheeler C, MacGowan RJ, Mohle-Boetani JC. Evaluation of routine HIV opt-out screening and continuum of care services following entry into eight prison reception centers—California, 2012. MMWR Morb Mortal Wkly Rep. 2016;65(7):178-181.
8. Schoenbachler BT, Smith BD, Sena AC, et al. Hepatitis C virus testing and linkage to care in North Carolina and South Carolina jails, 2012-2014. Public Health Rep. 2016;131(suppl 2): 98-104.
9. Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States—an analysis of costeffectiveness. N Engl J Med. 2005;352(6):586-595.
10. SAS Institute, Inc. SAS Version 9.4. Cary, NC: SAS Institute, Inc; 2013.
11. Stout JE, Katrak S, Goswami ND, et al. Integrated screening for tuberculosis and HIV in tuberculosis contact investigations: lessons learned in North Carolina. Public Health Rep. 2014; 129(suppl 1):21-25.
12. Person AK, Goswami ND, Bissette DJ, et al. Pairing Quanti- FERON gold in-tube with opt-out HIV testing in a tuberculosis contact investigation in the southeastern United States. AIDS Patient Care STDs. 2010;24(9):539-543.
13. Janssen RS, Onorato IM, Valdiserri RO, et al. Advancing HIV prevention: new strategies for a changing epidemic—United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(15): 329-332.
14. Divine BT, Greby SSM, Hunt KV, Kamb ML, Steketee RW, Warner L. Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep. 2001;50(RR-19):1-57.
15. Centers for Disease Control and Prevention. Prevalence and awareness of HIV infection among men who have sex with men—21 cities, United States, 2008. MMWR Morb Mortal Wkly Rep. 2010;59(37):1201-1207.
16. Flash CA, Pasalar S, Hemmige V, et al. Benefits of a routine opt-out HIV testing and linkage to care program for previously diagnosed patients in publicly funded emergency departments in Houston, TX. J Acquir Immune Defic Syndr. 2015;69(suppl 1):S8-S15.
17. Yalamanchili K, Saadeh S, Lepe R, Davis GL. The prevalence of hepatitis C virus infection in Texas: implications for future health care. Proc (Bayl Univ Med Cent). 2005;18(1):3-6.
18. Akiyama MJ, Kaba F, Rosner Z, Alper H, Holzman RS, Mac- Donald R. Hepatitis C screening of the “birth cohort” (born 1945-1965) and younger inmates of New York City jails. Am J Public Health. 2016;106(7):1276-1277.
19. Kim AY, Nagami EH, Birch CE, Bowen MJ, Lauer GM, McGovern BH. A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users. Hepatology. 2013;57(3):944-952.
20. Onofrey S, Kludt P, DeMaria A, et al. Hepatitis C virus infection among adolescents and young adults: Massachusetts, 2002-2009. MMWR Morb Mortal Wkly Rep. 2011;60(17): 537-541.
21. Zibbell JE, Iqbal K, Patel RC, et al; Centers for Disease Control and Prevention. Increases in hepatitis C virus infection related to injection drug use among persons aged _30 years—Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep. 2015;64(17): 453-458.